For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
National Review
The Return of the Cadillac Tax?
Like the phoenix, a key piece of the Affordable Care Act has risen from the ashes, resurrected, believe it or not, by the Republican Study Committee…
Blog
Free the Economy podcast: Paying for organs with Pete Jaworski
In this week’s episode we cover the future of AI and employment, why we shouldn’t trust Chinese economic statistics, and how the…
City Journal
A Solution in Search of a Problem
In his State of the Union address, President Biden touted the drug-price controls in his Inflation Reduction Act (IRA). Though the price controls have yet…
Search Posts
Op-Eds
Creating Cow Concerns Should Make Mad Consumers
<?xml:namespace prefix = st1 ns = “urn:schemas-microsoft-com:office:smarttags” />U.S. consumers are known for their affection for food, so it's a wonder most Americans…
Op-Eds
No, Not the NHS!
Whenever I hear the words “universal health care” — as I did during Sunday night's Democratic debate in <?xml:namespace prefix = st1 ns =…
Op-Eds
Technology for Life: How Biotech Will Save Billions from Starvation
Full article available in pdf format Today, most people around the world have access to a greater variety of nutritious…
Op-Eds
“Direct Action” The Tactics of Radical Activism: Part 1, How Environmental Groups Use Violent Tactics to Advance their
Full article available as a pdf. <?xml:namespace prefix = st1 ns = “urn:schemas-microsoft-com:office:smarttags” />July 8, 2000 –Kwajalein Atoll,…
Op-Eds
GMO Patent Nonsense
One of the most contentious issues in the debate over GM crops and foods is the existence of intellectual property protection and patents…
Op-Eds
Europe’s Dangerous Over-Precaution
European Union (EU) officials are deliberating on whether to apply the “precautionary principle” to nearly all chemicals in commerce within the EU—a move that could…